IFX-1
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for IFX-1, covering 2021-04-08 to 2025-02-11. Get the full timeline:
Most recent: Clinical Trial Update: Non-comparative Study of IFX-1 Alone or IFX-1+Pembrolizumab in Patients With Locally Advanced or Metastatic cSCC. [Phase 2]